Adding microfracture to an SVF-based arthroscopic pathway was associated with greater 24-month improvements in pain, function and MRI cartilage morphology in KL II-III knee osteoarthritis: A randomized controlled trial.
Yenigün MY., Demirel M., Bayram S., Canbolat N., Ergin ÖN., Aşık M.
Randomized Controlled Trial on Knee Osteoarthritis, Osteoarthritis, Cartilage Damage, published in Knee Surg Sports Traumatol Arthrosc (2026) — summary generated from the PubMed abstract.
Several human studies show positive signals, while research methods and sample sizes continue to develop.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Randomized Controlled Trial
- Journal
- Knee Surg Sports Traumatol Arthrosc (2026)
- Country
- Germany
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 41815082
- DOI
- 10.1002/ksa.70377
Abstract (original English)
Purpose To determine whether adding arthroscopic microfracture provides incremental clinical and magnetic resonance imaging (MRI)-based structural benefit within a standardized stromal vascular fraction (SVF)-based arthroscopic treatment pathway for moderate knee osteoarthritis. Methods In this prospective, single-centre randomized controlled trial, patients with Kellgren-Lawrence grade II-III knee osteoarthritis and a contained, full-thickness chondral lesion confirmed at arthroscopy were randomized to (1) arthroscopic debridement plus intra-articular SVF (SVF-only) or (2) the same debridement protocol augmented with microfracture followed by SVF (microfracture + SVF). SVF was harvested from subcutaneous abdominal adipose tissue and processed intraoperatively; the injectate volume was standardized to 5 mL. Total nucleated cell count (TNCC) was quantified for quality control. Outcomes included Visual Analogue Scale (VAS) pain, Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and Lysholm scores. MRI structural outcomes were assessed at baseline, 12 and 24 months using the Whole-Organ Magnetic Resonance Imaging Score (WORMS) cartilage morphology domain by blinded musculoskeletal radiologists. Results Fifty patients completed 24-month follow-up. Mean TNCC in the 5-mL injectate was 7.32 × 10 7 ± 2.47 × 10 7 cells and did not differ between groups (p = 0.42). A
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
Evidence level
Several human studies show positive signals, while research methods and sample sizes continue to develop.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level AMeta-analysisPubMed
Clinical Outcomes of Biologic Therapies for Knee Osteoarthritis: A Systematic Review and Meta-analysis of Studies With ≥12-Month Follow-up.
Meta-analysis on Knee Osteoarthritis, Osteoarthritis, published in Mod Rheumatol (2026) — summary generated from the PubMed abstract.
- 2026
Mod Rheumatol - Level AMeta-analysisEurope PMC
Towards optimized rehabilitation with regenerative therapy: A systematic review and meta-analysis on the effects of cell-based injections for knee osteoarthritis
Meta-analysis on Knee Osteoarthritis, Osteoarthritis, published in Knee Surg Sports Traumatol Arthrosc (2026) — summary generated from the PubMed abstract.
- 2026
Knee Surg Sports Traumatol Arthrosc - Level ASystematic ReviewPubMed
Intra-articular fat grafting for pain relief and functioning improvement in patients with knee osteoarthritis: systematic review.
Systematic Review on Knee Osteoarthritis, Osteoarthritis, published in Disabil Rehabil (2026) — summary generated from the PubMed abstract.
- 2026
Disabil Rehabil - Level ASystematic ReviewPubMed
Research Landscape of Stem Cell Applications in Musculoskeletal Tissue: A Scoping Review.
Systematic Review on Knee Osteoarthritis, Osteoarthritis, published in Cells (2026) — summary generated from the PubMed abstract.
- 2026
Cells - Level AMeta-analysisPubMed
Comparative efficacy of different doses of mesenchymal stem cells derived from different tissue sources for knee osteoarthritis: a systematic review and network meta-analysis of randomized controlled trials.
Meta-analysis with a reported sample of 602 on Knee Osteoarthritis, Osteoarthritis, Chronic Inflammation, Immune Modulation, published in PeerJ (2026) — summary generated from the PubMed abstract.
- 2026
- n = 602
PeerJ - Level AMeta-analysisEurope PMC
Influence of platelet-rich plasma composition on pain and functional performance in knee osteoarthritis: a systematic review and network meta-analysis
Meta-analysis with a reported sample of 5251 on Knee Osteoarthritis, Osteoarthritis, published in Knee Surg Relat Res (2026) — summary generated from the PubMed abstract.
- 2026
- n = 5251
Knee Surg Relat Res